Parkinson's Disease Q2
Unclaimed
Parkinson's Disease is a journal indexed in SJR in Neuroscience (miscellaneous) and Neurology (clinical) with an H index of 59. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1170 €. The scope of the journal is focused on parkinson's disease. It has an SJR impact factor of 0,753 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,753.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1170 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,753
SJR Impact factor59
H Index27
Total Docs (Last Year)176
Total Docs (3 years)1232
Total Refs491
Total Cites (3 years)176
Citable Docs (3 years)2.15
Cites/Doc (2 years)45.63
Ref/DocOther journals with similar parameters
Progress in Brain Research Q2
Journal of Comparative Neurology Q2
European Journal of Neuroscience Q2
Reviews in the Neurosciences Q2
Frontiers in Neuroscience Q2
Compare this journals
Aims and Scope
Best articles by citations
Remarkably Few Sputum Cultures from People with Parkinson's Disease during Hospital In-Patient Admission
View moreThe Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluida-Synuclein Levels in Parkinson's Disease: A Meta-Analysis
View moreCombining a Cognitive Concurrent Task with a Motor or Motor-Cognitive Task: Which Is Better to Differentiate Levels of Affectation in Parkinson's Disease?
View morePlasma Prolidase Activity and Oxidative Stress in Patients with Parkinson's Disease
View moreRecurrent Falls in People with Parkinson's Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors
View moreChanges to Intermediary Metabolites in Sporadic andLRRK2Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
View moreCognition Deficits in Parkinson's Disease: Mechanisms and Treatment
View moreThe Effects of Uric Acid, Serum Vitamin D3, and Their Interaction on Parkinson's Disease Severity
View moreValidation of the Persian Translation of the Swallowing Disturbance Questionnaire in Parkinson's Disease Patients
View moreMicroRNAs: Game Changers in the Regulation of a-Synuclein in Parkinson's Disease
View moreEffect of Exercise on Motor and Nonmotor Symptoms of Parkinson's Disease
View moreDeep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals
View morePentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson's Disease
View moreAbnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study
View moreAssociation of aBACE1Gene Polymorphism with Parkinson's Disease in a Norwegian Population
View moreLSVT-BIG Improves UPDRS III Scores at 4 Weeks in Parkinson's Disease Patients with Wearing Off: A Prospective, Open-Label Study
View moreEffectiveness of an Inpatient Movement Disorders Program for Patients with Atypical Parkinsonism
View moreEnhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease
View moreClinical Pain and Neuropsychological Functioning in Parkinson's Disease: Are They Related?
View moreComparing Balance Performance on Force Platform Measures in Individuals with Parkinson's Disease and Healthy Adults
View moreL-DOPA Uptake in Astrocytic Endfeet Enwrapping Blood Vessels in Rat Brain
View moreCognitive Stimulation for Individuals with Parkinson's Disease Dementia Living in Long-Term Care: Preliminary Data from a Randomized Crossover Pilot Study
View moreLong-Term Mortality Analysis in Parkinson's Disease Treated with Deep Brain Stimulation
View moreSafety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving =2000mg Daily Dose of Levodopa
View more
Comments